aTyr Pharma (NASDAQ:LIFE) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of aTyr Pharma (NASDAQ:LIFE – Free Report) in a report released on Friday morning. The firm issued a sell rating on the biotechnology company’s stock. A number of other research firms also recently commented on LIFE. HC Wainwright reiterated a buy rating and issued a $35.00 target price on shares […]
More Stories
Short Interest in Invesco BulletShares 2030 High Yield Corporate Bond ETF (NASDAQ:BSJU) Declines By 15.5%
Invesco BulletShares 2030 High Yield Corporate Bond ETF (NASDAQ:BSJU – Get Free Report) was the target of a large decrease...
Bruker Co. (NASDAQ:BRKR) Short Interest Down 12.2% in October
Bruker Co. (NASDAQ:BRKR – Get Free Report) was the recipient of a significant drop in short interest during the month...
AbbVie Target of Unusually High Options Trading (NYSE:ABBV)
AbbVie Inc. (NYSE:ABBV – Get Free Report) saw unusually large options trading on Thursday. Stock investors acquired 121,889 put options...
Turtle Creek Wealth Advisors LLC Buys 373 Shares of RTX Co. (NYSE:RTX)
Turtle Creek Wealth Advisors LLC boosted its stake in shares of RTX Co. (NYSE:RTX – Free Report) by 3.2% during...
River Street Advisors LLC Acquires New Shares in Exxon Mobil Co. (NYSE:XOM)
River Street Advisors LLC acquired a new stake in Exxon Mobil Co. (NYSE:XOM – Free Report) during the 3rd quarter,...
Bit Origin Ltd (NASDAQ:BTOG) Sees Significant Decline in Short Interest
Bit Origin Ltd (NASDAQ:BTOG – Get Free Report) saw a large decrease in short interest in October. As of October...